Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism CAIX inhibitors(Carbonic anhydrase IX inhibitors), HDAC2 inhibitors(Histone deacetylase 2 inhibitors), Tubulin inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Preclinical | - | 01 Aug 2025 | |
| Breast Cancer | Preclinical | - | 01 Aug 2025 | |
| Colorectal Cancer | Preclinical | - | 01 Aug 2025 | |
| Colorectal Cancer | Preclinical | - | 01 Aug 2025 | |
| Lung Cancer | Preclinical | - | 01 Aug 2025 | |
| Lung Cancer | Preclinical | - | 01 Aug 2025 | |
| Uterine Cervical Cancer | Preclinical | - | 01 Aug 2025 | |
| Uterine Cervical Cancer | Preclinical | - | 01 Aug 2025 |





